Ms Grégoire serves as chair of the board of Corvidia Therapeutics
Inc., US and executive chair of the board of EIP Pharma, Inc., US.
Further, Ms Grégoire serves as a member of the board of Perkin Elmer
Ms Grégoire is former president of Human Genetic Therapies Shire PLC,
US and Switzerland from 2007 to 2013. Prior to that, she was executive
chair of IDM Pharma Inc., US, from 2006 to 2007, and president and
chief executive officer in GlycoFi Inc., US from 2003 to 2004. From
1995 to 2003 Ms Grégoire held various leadership positions in Biogen,
Inc., in France and the US, recently as executive vice president of
Technical Operations. Prior to this, Ms Grégoire was at Merck and Co,
in clinical research and regulatory affairs in Canada, US and Belgium
for a period of 8 years.
Ms Grégoire was first elected to the Board of Novo Nordisk A/S in
March 2015 and has most recently been re-elected in March 2020. Her
term as a board member expires in March 2021.
In March 2020, the Board of Directors of Novo Nordisk A/S assessed
that Ms Grégoire is regarded as an independent board member as defined
in Section 3.2.1 of the Recommendations on Corporate Governance
designated by Nasdaq Copenhagen.
Ms Grégoire became member of the Audit Committee at Novo Nordisk
A/S in March 2015. In March 2020 the Board of Directors of Novo
Nordisk A/S assessed that Ms Grégoire qualifies as independent
pursuant to the US Securities Exchange Act.
Ms Grégoire became member of the Research & Development
Committee at Novo Nordisk A/S at the establishment in March 2017 and
Ms Grégoire became member of the Nomination Committee at Novo Nordisk
A/S in March 2018.
In January 2020 the Board of Directors assessed that the special
competences possessed by Ms Grégoire that are important for the
performance of her duties are her deep knowledge of the regulatory
environment in both the US and the EU, having experience with all
phases of the product life cycle, including discovery, registration,
pre-launch and managing the life cycle while on the market. In
addition, Ms Grégoire has financial insight, including into P&L responsibility.
Ms Grégoire is both a Canadian and US national, born November 1961.